Newsletter | November 10, 2025

11.10.25 -- Business Of Biotech On Location In South Florida

FEATURED ARTICLE

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

The Business of Biotech is on location in Miami! For the first episode in this four-part series on the biotech scene in South Florida, Raquel Cabo, Founder and President of the Miami Biotech Collective, talks about her experiences as a member of the founding team at Ovid Therapeutics, why South Florida needed an organization to connect regional drug developers, and more.

INDUSTRY INSIGHTS

Pregnant Women: An Underrepresented Group In Clinical Trials

Integrating pregnant women into clinical trials through strategic partnerships, accessible trial locations, and robust informed consent processes is essential.

Conducting Early Phase Clinical Trials In Diverse Healthy Populations

Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.

Best Practices For Clinical Trial Marketing And Advertising

Four out of five clinical trials fall short of their recruitment targets. Adopting innovative strategies can significantly improve patient recruitment, accelerate trials, and support the development of new therapies.

Innovation In Filtration: New Challenges Met By Traditional Science

Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.

5 Outdated Practices Holding Back Modern Bioanalysis

Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

Candidate Screening And Feasibility Studies For Viral Gene Therapies

Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.